Sander DS - Search Results

1

Rotavirus immunoglobulin a responses stimulated by each of 3 doses of a quadrivalent human/bovine reassortant rotavirus vaccine.

Ward RL, Bernstein DI, Smith VE, Sander DS, Shaw A, Eiden JJ, Heaton P, Offit PA, Clark HF. Ward RL, et al. Among authors: sander ds. J Infect Dis. 2004 Jun 15;189(12):2290-3. doi: 10.1086/421248. Epub 2004 May 25. J Infect Dis. 2004. PMID: 15181577 Clinical Trial.

2

Reductions in cross-neutralizing antibody responses in infants after attenuation of the human rotavirus vaccine candidate 89-12.

Ward RL, Kirkwood CD, Sander DS, Smith VE, Shao M, Bean JA, Sack DA, Bernstein DI. Ward RL, et al. Among authors: sander ds. J Infect Dis. 2006 Dec 15;194(12):1729-36. doi: 10.1086/509623. Epub 2006 Nov 6. J Infect Dis. 2006. PMID: 17109346 Clinical Trial.

3

Protection from rotavirus reinfection: 2-year prospective study.

Bernstein DI, Sander DS, Smith VE, Schiff GM, Ward RL. Bernstein DI, et al. Among authors: sander ds. J Infect Dis. 1991 Aug;164(2):277-83. doi: 10.1093/infdis/164.2.277. J Infect Dis. 1991. PMID: 1649875

4

Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants.

Bernstein DI, Smith VE, Sander DS, Pax KA, Schiff GM, Ward RL. Bernstein DI, et al. Among authors: sander ds. J Infect Dis. 1990 Nov;162(5):1055-62. doi: 10.1093/infdis/162.5.1055. J Infect Dis. 1990. PMID: 2172394 Clinical Trial.

5

Effect of vaccination on serotype-specific antibody responses in infants administered WC3 bovine rotavirus before or after a natural rotavirus infection.

Ward RL, Sander DS, Schiff GM, Bernstein DI. Ward RL, et al. Among authors: sander ds. J Infect Dis. 1990 Dec;162(6):1298-303. doi: 10.1093/infdis/162.6.1298. J Infect Dis. 1990. PMID: 2172404 Clinical Trial.

6

Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12.

Bernstein DI, Smith VE, Sherwood JR, Schiff GM, Sander DS, DeFeudis D, Spriggs DR, Ward RL. Bernstein DI, et al. Among authors: sander ds. Vaccine. 1998 Feb;16(4):381-7. doi: 10.1016/s0264-410x(97)00210-7. Vaccine. 1998. PMID: 9607059 Clinical Trial.

7

Immunodominance of the VP4 neutralization protein of rotavirus in protective natural infections of young children.

Ward RL, McNeal MM, Sander DS, Greenberg HB, Bernstein DI. Ward RL, et al. Among authors: sander ds. J Virol. 1993 Jan;67(1):464-8. doi: 10.1128/JVI.67.1.464-468.1993. J Virol. 1993. PMID: 8416378 Free PMC article.

8

Attenuation of a human rotavirus vaccine candidate did not correlate with mutations in the NSP4 protein gene.

Ward RL, Mason BB, Bernstein DI, Sander DS, Smith VE, Zandle GA, Rappaport RS. Ward RL, et al. Among authors: sander ds. J Virol. 1997 Aug;71(8):6267-70. doi: 10.1128/JVI.71.8.6267-6270.1997. J Virol. 1997. PMID: 9223531 Free PMC article.

9

Shedding of rotavirus after administration of the tetravalent rhesus rotavirus vaccine.

Ward RL, Dinsmore AM, Goldberg G, Sander DS, Rappaport RS, Zito ET. Ward RL, et al. Among authors: sander ds. Pediatr Infect Dis J. 1998 May;17(5):386-90. doi: 10.1097/00006454-199805000-00008. Pediatr Infect Dis J. 1998. PMID: 9613651 Clinical Trial.

10

Isolation of a human rotavirus containing a bovine rotavirus VP4 gene that suppresses replication of other rotaviruses in coinfected cells.

Ward RL, Jin Q, Nakagomi O, Sander DS, Gentsch JR. Ward RL, et al. Among authors: sander ds. Arch Virol. 1996;141(3-4):615-33. doi: 10.1007/BF01718321. Arch Virol. 1996. PMID: 8645099

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters